The patient is demonstrating resistance to the therapeutic process, which is a common defense mechanism that occurs when therapy begins to approach core psychological conflicts

The most appropriate response is to interpret the resistance directly by stating that the patient appears to be avoiding deeper material and that this avoidance pattern likely reflects how he manages uncomfortable emotions in other areas of his life. Confronting the resistance will help the patient develop insight into his defensive patterns and facilitate therapeutic progress. Framing the patient's behavior as 'resistance' and confronting it directly is likely to escalate the rupture and further damage the alliance. Modern psychotherapy research reconceptualizes resistance as a relational signal — often indicating a rupture in the therapeutic alliance rather than an intrapsychic defense.

The patient's withdrawal, reduced engagement, and pessimism about therapy represent a withdrawal-type alliance rupture

This occurs when the patient moves away from the therapist or the therapeutic process in response to a perceived strain in the relationship. The most appropriate response is for the PMHNP to metacommunicate about the observed changes by gently naming the shift in engagement, expressing curiosity about the patient's experience of therapy, and exploring whether something occurred in the therapeutic relationship that contributed to the change. This creates space for repair of the alliance. This correctly identifies a withdrawal-type rupture (one of two rupture types described by Safran and Muran, along with confrontation ruptures). Withdrawal ruptures manifest as emotional disengagement, compliance without genuine participation, and avoidance.

The patient's behavioral changes suggest a worsening of his depressive symptoms rather than a therapeutic relationship issue

The most appropriate response is to conduct a PHQ-9 assessment and consider augmenting his current treatment with psychopharmacological intervention. Increased withdrawal, brevity in communication, and hopelessness about treatment outcomes are classic indicators of depressive symptom exacerbation. The PMHNP should prioritize symptom management through medication evaluation rather than exploring relational dynamics that may not be relevant to the clinical picture. While depressive symptom exacerbation should always be considered, the pattern described — active engagement followed by sudden withdrawal, incomplete homework, and statements questioning therapy's efficacy — is more consistent with an alliance rupture.

The patient's behavior indicates that CBT may not be the appropriate therapeutic modality for his presentation

The most appropriate response is to discuss switching to a different evidence-based therapy such as psychodynamic psychotherapy or interpersonal therapy. Some patients are not suited to the structured, homework-oriented nature of CBT, and continued insistence on this modality when the patient is disengaging will only further erode the therapeutic relationship. The PMHNP should present alternative therapy options and allow the patient to choose a modality that feels more comfortable. Changing the therapy modality in response to an alliance rupture avoids addressing the relational issue directly and models avoidance rather than repair. Alliance ruptures can occur in any therapeutic modality, and the rupture itself — when addressed skillfully — often becomes a powerful therapeutic moment.